REFERENCES
- Russell I. J. A metabolic basis for fibromyalgia syndrome Progress in Fibromyalgia and Myofascial Pain, H. Vaeroy, H. Merskey. Elsevier Science Publishers, San Antonio 1993; 283–309
- Eisinger J. Metabolic abnormalities in fibromyalgia. Clin Bull Myo Ther 1998; 3: 3–21
- Russell I. J. Advances in fibromyalgia: Possible role for central neurochemicals. Am J Med Sci 1998; 315(6)377–384
- Jain A. K., Carruthers B. M., Van de Sande M. I., Barron S. R., Donaldson C CS, Dunne J. V., Gingrich E, Heffez D. S., Leung F YK, Malone D. G., Romano T. J., Russell I. J., Saul D, Seibel D. G. Fibromyalgia syndrome: Canadian clinical working case definition, diagnostic and treatment protocols-A consensus document. J Musculoske Pain 2003; 11(4)3–107
- Shah J. P., Phillips T. M., Danoff J. V., Gerber L. H. An in-vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol 2005; 99(5)1977–1984
- Neeck G, Crofford L. J. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 2000; 26(4)989–1002
- Eisinger J, Gandolfo C, Zakarian H, Ayavou T. Reactive oxygen species, antioxidant status and fibromyalgia. J Musculoske Pain 1997; 5(4)5–16
- Bennett R. M. The contribution of muscle to the generation of fibromyalgia symptomatology. J Musculoske Pain 1996; 4(1–2)35–52
- Eisinger J. Les fibromyalgies: I. La clinique II. Les investigations paracliniques. Myalgies International 2004; 3(1)5–64